Furthermore, high plasma fibrinogen was found to be correlated with poor response to trastuzumab treatment in HER2 positive BC patients [43] and circulating levels of factor VIII (FVIII) were significantly associated with axillary lymph node involvement, number of metastatic nodes and HER2 status [44]. This evidence concerns the gene ERBB2 and breast cancer.